×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions for Nabriva Therapeutics plc (NBRV)

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
NBRVNabriva Therapeutics plcGelone Steven P.DirectorJan 29, 2023Option Exercise$1.5014021014,283Jan 31, 2023, 08:56 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RDirectorJan 29, 2023Option Exercise$1.5043164711,989Jan 31, 2023, 08:55 PM
NBRVNabriva Therapeutics plcGelone Steven P.President and COOJan 06, 2023Option Exercise$1.305614,423Jan 10, 2023, 05:58 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerJan 06, 2023Option Exercise$1.30111412,420Jan 10, 2023, 05:56 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerDec 31, 2022Option Exercise$1.895912,431Jan 04, 2023, 06:09 PM
NBRVNabriva Therapeutics plcGelone Steven P.President and COODec 31, 2022Option Exercise$1.893614,428Jan 04, 2023, 06:08 PM
NBRVNabriva Therapeutics plcGelone Steven P.President and COODec 06, 2022Option Exercise$2.024814,431Dec 08, 2022, 04:37 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerDec 06, 2022Option Exercise$2.0291812,436Dec 08, 2022, 04:34 PM
NBRVNabriva Therapeutics plcGelone Steven P.President and COONov 30, 2022Option Exercise$2.253714,435Dec 02, 2022, 05:17 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerNov 30, 2022Option Exercise$2.2551112,445Dec 02, 2022, 05:15 PM
NBRVNabriva Therapeutics plcGelone Steven P.President and COONov 06, 2022Option Exercise$2.244914,438Nov 08, 2022, 05:26 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerNov 06, 2022Option Exercise$2.24102212,450Nov 08, 2022, 05:24 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerOct 31, 2022Option Exercise$2.5451312,460Nov 01, 2022, 05:08 PM
NBRVNabriva Therapeutics plcGelone Steven P.President and COOOct 31, 2022Option Exercise$2.543814,442Nov 01, 2022, 05:06 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerOct 06, 2022Option Exercise$2.7292412,465Oct 11, 2022, 05:03 PM
NBRVNabriva Therapeutics plcGelone Steven P.President and COOOct 06, 2022Option Exercise$2.7241114,445Oct 11, 2022, 05:00 PM
NBRVNabriva Therapeutics plcGelone Steven P.President and COOSep 30, 2022Option Exercise$2.083614,449Oct 04, 2022, 09:36 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerSep 30, 2022Option Exercise$2.0851012,474Oct 04, 2022, 09:31 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerSep 06, 2022Option Exercise$0.1622535311,977Sep 07, 2022, 06:00 PM
NBRVNabriva Therapeutics plcGelone Steven P.President and COOSep 06, 2022Option Exercise$0.168914361,311Sep 07, 2022, 05:57 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerAug 31, 2022Option Exercise$0.1610718312,202Sep 01, 2022, 06:38 PM
NBRVNabriva Therapeutics plcGelone Steven P.President and COOAug 31, 2022Option Exercise$0.166110361,400Sep 01, 2022, 06:35 PM
NBRVNabriva Therapeutics plcGelone Steven P.President and COOAug 06, 2022Option Exercise$0.188916361,461Aug 08, 2022, 05:45 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerAug 06, 2022Option Exercise$0.1822542312,309Aug 08, 2022, 05:44 PM
NBRVNabriva Therapeutics plcBURGESS DANIEL DDirectorAug 02, 2022Sale$0.1911,3412,15610,384Aug 04, 2022, 06:24 PM
NBRVNabriva Therapeutics plcBroom Colin MDDirectorAug 02, 2022Sale$0.195,3391,01536,523Aug 04, 2022, 06:22 PM
NBRVNabriva Therapeutics plcWebster Stephen WDirectorAug 02, 2022Sale$0.197,8261,48711,447Aug 04, 2022, 06:20 PM
NBRVNabriva Therapeutics plcCORRIGAN MARKDirectorAug 02, 2022Sale$0.1910,2971,9567,203Aug 04, 2022, 06:19 PM
NBRVNabriva Therapeutics plcRowland Charles A JrDirectorAug 01, 2022Sale$0.178,4961,48715,277Aug 03, 2022, 09:48 PM
NBRVNabriva Therapeutics plcBourdow Carrie L.DirectorAug 01, 2022Sale$0.178,5401,4879,933Aug 03, 2022, 09:47 PM
NBRVNabriva Therapeutics plcDalton LisaDirectorJul 31, 2022Option Exercise$0.188,4001,5049,100Aug 03, 2022, 09:46 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerJul 31, 2022Option Exercise$0.1810719312,534Aug 03, 2022, 09:45 PM
NBRVNabriva Therapeutics plcGelone Steven P.President and COOJul 31, 2022Option Exercise$0.186111361,550Aug 03, 2022, 09:43 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerJul 06, 2022Option Exercise$0.1822541312,641Jul 07, 2022, 04:11 PM
NBRVNabriva Therapeutics plcGelone Steven P.President and COOJul 06, 2022Option Exercise$0.188916361,611Jul 07, 2022, 04:10 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerJun 30, 2022Option Exercise$0.1810719312,866Jul 01, 2022, 06:08 PM
NBRVNabriva Therapeutics plcGelone Steven P.President and COOJun 30, 2022Option Exercise$0.186111361,700Jul 01, 2022, 06:06 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerJun 06, 2022Option Exercise$0.2022545312,973Jun 07, 2022, 04:47 PM
NBRVNabriva Therapeutics plcGelone Steven P.President and COOJun 06, 2022Option Exercise$0.208918361,761Jun 07, 2022, 04:46 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerMay 31, 2022Option Exercise$0.2110722313,198Jun 02, 2022, 04:10 PM
NBRVNabriva Therapeutics plcGelone Steven P.President and COOMay 31, 2022Option Exercise$0.216113361,850Jun 02, 2022, 04:09 PM
NBRVNabriva Therapeutics plcGelone Steven P.President and COOMay 06, 2022Option Exercise$0.268923361,911May 09, 2022, 06:33 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerMay 06, 2022Option Exercise$0.2622558313,305May 09, 2022, 06:32 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerApr 30, 2022Option Exercise$0.3110733313,530May 03, 2022, 04:59 PM
NBRVNabriva Therapeutics plcGelone Steven P.President and COOApr 30, 2022Option Exercise$0.316119362,000May 03, 2022, 04:58 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerApr 06, 2022Option Exercise$0.4121990313,637Apr 08, 2022, 04:16 PM
NBRVNabriva Therapeutics plcGelone Steven P.President and COOApr 06, 2022Option Exercise$0.418936362,061Apr 08, 2022, 04:15 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerMar 31, 2022Option Exercise$0.4210444313,856Apr 04, 2022, 06:27 PM
NBRVNabriva Therapeutics plcGelone Steven P.President and COOMar 31, 2022Option Exercise$0.426126362,150Apr 04, 2022, 06:26 PM
NBRVNabriva Therapeutics plcGelone Steven P.President and COOMar 06, 2022Option Exercise$0.438938362,211Mar 08, 2022, 04:14 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerMar 06, 2022Option Exercise$0.43263113313,960Mar 08, 2022, 04:12 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerFeb 28, 2022Option Exercise$0.4512556314,223Mar 02, 2022, 07:51 PM
NBRVNabriva Therapeutics plcGelone Steven P.President and COOFeb 28, 2022Option Exercise$0.456127362,300Mar 02, 2022, 07:50 PM
NBRVNabriva Therapeutics plcGelone Steven P.President and COOFeb 06, 2022Option Exercise$0.4810651362,361Feb 08, 2022, 04:26 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerFeb 06, 2022Option Exercise$0.48263126314,348Feb 08, 2022, 04:25 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerJan 29, 2022Option Exercise$0.4510,7664,845314,736Feb 01, 2022, 08:47 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerJan 31, 2022Option Exercise$0.4812560314,611Feb 01, 2022, 08:47 PM
NBRVNabriva Therapeutics plcGelone Steven P.President and COOJan 29, 2022Option Exercise$0.453,4831,567362,540Feb 01, 2022, 08:44 PM
NBRVNabriva Therapeutics plcGelone Steven P.President and COOJan 31, 2022Option Exercise$0.487335362,467Feb 01, 2022, 08:44 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerJan 06, 2022Option Exercise$0.58270157325,502Jan 10, 2022, 04:19 PM
NBRVNabriva Therapeutics plcGelone Steven P.President and COOJan 06, 2022Option Exercise$0.5811064366,023Jan 10, 2022, 04:18 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerDec 28, 2021Buy$0.57100,00057,320325,879Dec 29, 2021, 09:32 PM
NBRVNabriva Therapeutics plcNaftzger J. ChristopherGeneral Counsel and Corp SecDec 27, 2021Buy$0.597,0004,1307,000Dec 28, 2021, 07:04 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerDec 06, 2021Option Exercise$0.72225162225,879Dec 08, 2021, 05:14 PM
NBRVNabriva Therapeutics plcGelone Steven P.President and COODec 06, 2021Option Exercise$0.729266366,196Dec 08, 2021, 05:13 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerNov 30, 2021Option Exercise$0.7810783226,104Dec 02, 2021, 06:31 PM
NBRVNabriva Therapeutics plcGelone Steven P.President and COONov 30, 2021Option Exercise$0.786349366,288Dec 02, 2021, 06:28 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerNov 06, 2021Option Exercise$1.33225299226,211Nov 09, 2021, 05:38 PM
NBRVNabriva Therapeutics plcGelone Steven P.President and COONov 06, 2021Option Exercise$1.3392122366,351Nov 09, 2021, 05:36 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerOct 31, 2021Option Exercise$1.15107123226,436Nov 01, 2021, 07:51 PM
NBRVNabriva Therapeutics plcGelone Steven P.President and COOOct 31, 2021Option Exercise$1.156372366,443Nov 01, 2021, 07:50 PM
NBRVNabriva Therapeutics plcGelone Steven P.President and COOOct 06, 2021Option Exercise$1.089299366,506Oct 08, 2021, 04:41 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerOct 06, 2021Option Exercise$1.08225243226,543Oct 08, 2021, 04:39 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerSep 30, 2021Option Exercise$1.19107127226,768Oct 04, 2021, 04:14 PM
NBRVNabriva Therapeutics plcGelone Steven P.President and COOSep 30, 2021Option Exercise$1.196375366,598Oct 04, 2021, 04:09 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerSep 14, 2021Buy$1.1350,00056,500226,875Sep 15, 2021, 08:00 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerSep 06, 2021Option Exercise$1.11225250176,875Sep 08, 2021, 05:27 PM
NBRVNabriva Therapeutics plcGelone Steven P.President and COOSep 06, 2021Option Exercise$1.1193103366,661Sep 08, 2021, 05:25 PM
NBRVNabriva Therapeutics plcGelone Steven P.President and COOAug 31, 2021Option Exercise$1.066367366,754Sep 02, 2021, 04:09 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerAug 31, 2021Option Exercise$1.06107113177,100Sep 02, 2021, 04:07 PM
NBRVNabriva Therapeutics plcCrotty RobertGen Counsel & Corp SecretaryAug 31, 2021Option Exercise$1.06373941,194Sep 02, 2021, 04:06 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerAug 06, 2021Option Exercise$1.17225263177,207Aug 10, 2021, 05:16 PM
NBRVNabriva Therapeutics plcGelone Steven P.President and COOAug 06, 2021Option Exercise$1.1792108366,817Aug 10, 2021, 05:15 PM
NBRVNabriva Therapeutics plcCrotty RobertGen Counsel & Corp SecretaryAug 06, 2021Option Exercise$1.17748741,231Aug 10, 2021, 05:13 PM
NBRVNabriva Therapeutics plcWebster Stephen WDirectorAug 02, 2021Sale$1.2077793219,273Aug 04, 2021, 09:08 PM
NBRVNabriva Therapeutics plcBURGESS DANIEL DDirectorAug 02, 2021Sale$1.201,1251,35021,725Aug 04, 2021, 09:07 PM
NBRVNabriva Therapeutics plcBroom Colin MDDirectorAug 02, 2021Sale$1.2053163741,862Aug 04, 2021, 09:06 PM
NBRVNabriva Therapeutics plcRowland Charles A JrDirectorAug 02, 2021Sale$1.2077793223,773Aug 04, 2021, 09:05 PM
NBRVNabriva Therapeutics plcBourdow Carrie L.DirectorAug 02, 2021Sale$1.2077793218,473Aug 04, 2021, 09:04 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerJul 31, 2021Option Exercise$1.10107118177,432Aug 03, 2021, 04:09 PM
NBRVNabriva Therapeutics plcGelone Steven P.President and COOJul 31, 2021Option Exercise$1.106369366,909Aug 03, 2021, 04:07 PM
NBRVNabriva Therapeutics plcCrotty RobertGen Counsel & Corp SecretaryJul 31, 2021Option Exercise$1.10374141,305Aug 03, 2021, 04:06 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerJul 06, 2021Option Exercise$1.27225286177,539Jul 08, 2021, 04:11 PM
NBRVNabriva Therapeutics plcGelone Steven P.President and COOJul 06, 2021Option Exercise$1.2792117366,972Jul 08, 2021, 04:09 PM
NBRVNabriva Therapeutics plcCrotty RobertGen Counsel & Corp SecretaryJul 06, 2021Option Exercise$1.27749441,342Jul 08, 2021, 04:09 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerJun 30, 2021Option Exercise$1.35107144177,764Jul 02, 2021, 04:06 PM
NBRVNabriva Therapeutics plcGelone Steven P.President and COOJun 30, 2021Option Exercise$1.356385367,064Jul 02, 2021, 04:05 PM
NBRVNabriva Therapeutics plcCrotty RobertGen Counsel & Corp SecretaryJun 30, 2021Option Exercise$1.35375041,416Jul 02, 2021, 04:04 PM
NBRVNabriva Therapeutics plcGelone Steven P.President and COOJun 06, 2021Option Exercise$1.3492123367,127Jun 08, 2021, 04:09 PM
NBRVNabriva Therapeutics plcCrotty RobertGen Counsel & Corp SecretaryJun 06, 2021Option Exercise$1.34739841,453Jun 08, 2021, 04:05 PM